Jun 12, 2019 / 05:00PM GMT
Patrick B. Donnelly - Goldman Sachs Group Inc., Research Division - Equity Analyst
I think we can look to get started. Thanks for being here. I'm Patrick Donnelly, the tools and diagnostics analyst here at Goldman Sachs. Happy to have Francis deSouza, CEO of Illumina, with us today. It's open Q&A so feel free to just raise your hand, and we'll try to get to you. But Francis, I think you wanted to read a safe harbor statement before we get started.
Francis A. deSouza - Illumina, Inc. - CEO, President & Director
Yes. Thank you, Patrick. And good morning to all of you, and thank you for attending our session this morning.
Before we start, I'd like to remind you that my comments today could include forward-looking statements. You should refer to our SEC filings for a discussion of the risks and uncertainties that could cause results to differ materially from our current expectations. It's our intent that all forward-looking statements regarding our financial results and commercial activity made during today's discussion will be protected under the
Illumina Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 12, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers